SAVA Cassava Sciences, Inc.

Cassava Sciences, Inc. is a biopharmaceutical company that develops novel drugs.

$43.48  -1.00 (-2.25%)
As of 03/05/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
01/11/2000
25,578,673
7,149,672
$1,110,370,195
0.00%
SEC Edgar Online
10-Q
10-K
14817C107
US14817C1071
BJVLKZ9

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
42.85
0.00
-21.82%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy